Sequenom to Embark on Clinical Validation Study for Trisomy 21 Test in January
January 04, 2011
Sequenom to Embark on Clinical Validation Study for Trisomy 21 Test in January
Results from an equivalency study using the HiSeq 2000 "met pre-specified requirements that now allow us to proceed confidently with the validation study," said Sequenom CEO Harry Hixson.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Sequenom Says Competitors Will Have to License IP for Noninvasive T21 Detection Tests
July 27, 2011 / Clinical Sequencing News - Sequenom Aiming to Submit PMA Application to FDA for T21 Test by End of 2012
June 15, 2011 / Clinical Sequencing News - Sequenom Starts Technical Validation Study for Next-Gen-Sequencing-Based T21 Test
August 10, 2010 / In Sequence - Sequenom Outlicenses Technology for T21 Test, Returns Rights of Separate Patent to TrovaGene
August 17, 2011 / Clinical Sequencing News - Sequenom Ramps up Hiring, Licenses Additional Technology as it Nears Launch of T21 Test
August 9, 2011 / Clinical Sequencing News